Want to see ABCL full AI Analyst Report?
AbCellera Biologics (ABCL) Ownership Overview
38.60% Insiders
4.40% Mutual Funds
18.51% Other Institutional Investors
1.67% ETFs
36.81% Public Companies and Individual Investors
The ownership structure of AbCellera Biologics (ABCL) stock is a mix of institutional, retail, and individual investors. Approximately 24.58% of the company’s stock is owned by Institutional Investors, 38.60% is owned by Insiders, and 36.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 24, 2026 | xxxxxxxxxxxxx | $570442 | |
Aug 18, 2026 | xxxxxxxxxxxxx | $110300 | |
Aug 14, 2026 | xxxxxxxxxxxxx | $481033 | |
Aug 14, 2026 | xxxxxxxxxxxxx | $383904 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $259145283 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $22488123 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 56,984,009 | Insider | 17.59% | 642,779,622 | |
| 56,134,097 | Insider | 17.32% | 633,192,614 | |
| 33,012,138 | Institution | 10.19% | 372,376,917 | |
| 13,361,096 | Institution | 4.12% | 150,713,163 | |
| 9,613,674 | Insider | 2.97% | 108,442,243 | |
| 3,149,385 | Institution | 0.97% | 35,525,063 | |
| 2,864,729 | Institution | 0.88% | 32,314,143 | |
| 1,491,642 | Insider | 0.46% | 16,825,722 | |
| 1,159,196 | Institution | 0.36% | 13,075,731 | |
| 740,694 | Institution | 0.23% | 8,355,028 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,361,096 | Institution | 4.12% | 150,713,163 | |
| 340,523 | Institution | 0.11% | 3,841,099 | |
| 249,240 | Institution | 0.08% | 2,811,427 | |
| 176,961 | Institution | 0.05% | 1,996,120 | |
| 58,472 | Institution | 0.02% | 659,564 | |
| 44,214 | Institution | 0.01% | 498,734 | |
| 29,481 | Institution | <0.01% | 332,546 | |
| 9,145 | Institution | <0.01% | 103,156 | |
| 3 | Institution | 0.00% | 34 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,755,861 | Institution | 0.54% | 19,806,112 | |
| 1,164,672 | Institution | 0.36% | 13,137,500 | |
| 573,621 | Institution | 0.18% | 6,585,169 | |
| 565,004 | Institution | 0.17% | 6,373,245 | |
| 243,602 | Institution | 0.08% | 2,796,551 | |
| 168,564 | Institution | 0.05% | 1,935,115 | |
| 135,456 | Institution | 0.04% | 1,555,035 | |
| 64,811 | Institution | 0.02% | 744,030 | |
| 59,857 | Institution | 0.02% | 675,187 | |
| 39,804 | Institution | 0.01% | 456,950 |
FAQ
Who Owns AbCellera Biologics (ABCL)?
According to the latest TipRanks data, approximately 18.51% of the company's stock is held by institutional investors, 38.60% is held by insiders, and 36.81% is held by retail investors.
What percentage of AbCellera Biologics (ABCL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.51% of AbCellera Biologics (ABCL) stock is held by institutional investors.
What percentage of AbCellera Biologics (ABCL) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.81% of AbCellera Biologics (ABCL) stock is held by retail investors.
Who owns the most shares of AbCellera Biologics (ABCL)?
Carl L. G. Hansen owns the most shares of AbCellera Biologics (ABCL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.